‘Breaking Down Barriers to a Personalized Approach to Medications to Reduce Adverse Drug Effects’
HOUSTON, March 22, 2022 /PRNewswire/ — The American Society of Pharmacovigilance (ASP) will virtually address members of the U.S. Congress and their staff on March 29, from 12:30 p.m. to 1:30 p.m. EST, related to ASP’s continuing mission to rapidly and dramatically reduce the high rate of suffering and mortality due to adverse drug events (ADE) – the fourth leading cause of death in the United States. The ASP is a 501(c)(3) nonprofit organization who convenes the Standardizing Laboratory Practices in Pharmacogenomics (STRIPE Initiative) and is a national biomedical and healthcare network with membership open to all healthcare professionals. Those interested in this important congressional briefing may register online.
